Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.

Kumarasinghe MP, Morey A, Bilous M, Farshid G, Francis G, Lampe G, McCue G, Von Neumann-Cosel V, Fox SB.

Pathology. 2017 Oct;49(6):575-581. doi: 10.1016/j.pathol.2017.05.009. Epub 2017 Aug 18.

PMID:
28823752
2.

Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study.

Pathmanathan N, Geng JS, Li W, Nie X, Veloso J, Wang J, Hill J, Mccloud P, Bilous M.

Asia Pac J Clin Oncol. 2017 Jun;13(3):249-260. doi: 10.1111/ajco.12653. Epub 2016 Dec 23.

PMID:
28008715
3.

Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.

Morey AL, Brown B, Farshid G, Fox SB, Francis GD, McCue G, von Neumann-Cosel V, Bilous M.

Pathology. 2016 Oct;48(6):535-42. doi: 10.1016/j.pathol.2016.05.007. Epub 2016 Aug 25.

PMID:
27567228
4.

Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study.

Pathmanathan N, Geng JS, Li W, Nie X, Veloso J, Hill J, McCloud P, Bilous M.

Asia Pac J Clin Oncol. 2016 Dec;12(4):369-379. doi: 10.1111/ajco.12514. Epub 2016 Jun 23.

PMID:
27334915
5.

Reply to E.A. Rakha et al.

Wolff AC, Hammond ME, Hicks DG, Allison KH, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Dowsett M, McShane LM, Hayes DF.

J Clin Oncol. 2015 Apr 10;33(11):1302-4. doi: 10.1200/JCO.2014.59.7559. Epub 2015 Mar 9. No abstract available.

PMID:
25753441
6.

Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task force.

Kim KM, Bilous M, Chu KM, Kim BS, Kim WH, Park YS, Ryu MH, Sheng W, Wang J, Chao Y, Ying J, Zhang S.

Asia Pac J Clin Oncol. 2014 Dec;10(4):297-307. doi: 10.1111/ajco.12263. Epub 2014 Sep 16. Review.

7.

Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology.

Pathmanathan N, Renthawa J, French JR, Edstrom-Elder E, Hall G, Mahajan H, Teh C, Bilous MA.

ANZ J Surg. 2014 Oct;84(10):730-4. doi: 10.1111/ans.12668. Epub 2014 Jun 5.

PMID:
24899463
8.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF; American Society of Clinical Oncology; College of American Pathologists.

J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.

PMID:
24101045
9.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF; American Society of Clinical Oncology; College of American Pathologists.

Arch Pathol Lab Med. 2014 Feb;138(2):241-56. doi: 10.5858/arpa.2013-0953-SA. Epub 2013 Oct 7.

10.

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity.

Hanna WM, Rüschoff J, Bilous M, Coudry RA, Dowsett M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G.

Mod Pathol. 2014 Jan;27(1):4-18. doi: 10.1038/modpathol.2013.103. Epub 2013 Jun 28. Review.

11.

Universal screening to identify gestational diabetes: a multi-centre study in the North of England.

Hayes L, Bilous R, Bilous M, Brandon H, Crowder D, Emmerson C, Lewis-Barned N, Bell R.

Diabetes Res Clin Pract. 2013 Jun;100(3):e74-7. doi: 10.1016/j.diabres.2013.03.019. Epub 2013 Apr 2.

PMID:
23561059
12.

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.

Bilous M, Morey AL, Armes JE, Bell R, Button PH, Cummings MC, Fox SB, Francis GD, Waite B, McCue G, Raymond WA, Robbins PD, Farshid G.

Breast Cancer Res Treat. 2012 Jul;134(2):617-24. doi: 10.1007/s10549-012-2093-6. Epub 2012 Jun 8.

13.

[Analysis of results of excerpts of generalized parametric indicators of facet classification of occupations in medicine, practical, industrial pharmacy, cosmetology and major of related occupations introduced to State classifiers 003:2010].

Ponomarenko MS, Zahoriĭ HV, Babs'kyĭ AA, Trokhumchuk VV, Ferorchuk IuV, Horban' OM, Drozdova AP, Bilous MV, Hrihoriuk IuM, Siatunia MV.

Lik Sprava. 2011 Jul-Sep;(5-6):115-20. Ukrainian.

PMID:
22606903
14.

Triple-negative breast cancer: making the most of a misnomer.

McCarthy N, Mitchell G, Bilous M, Wilcken N, Lindeman GJ.

Asia Pac J Clin Oncol. 2012 Jun;8(2):145-55. doi: 10.1111/j.1743-7563.2012.01533.x. Review.

PMID:
22524573
15.

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.

Fox SB, Kumarasinghe MP, Armes JE, Bilous M, Cummings MC, Farshid G, Fitzpatrick N, Francis GD, McCloud PI, Raymond W, Morey A.

Am J Surg Pathol. 2012 Apr;36(4):577-82. doi: 10.1097/PAS.0b013e318244adbb.

PMID:
22314190
16.

HER2 testing in gastric cancer: a practical approach.

Rüschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G.

Mod Pathol. 2012 May;25(5):637-50. doi: 10.1038/modpathol.2011.198. Epub 2012 Jan 6.

17.

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis.

Houssami N, Macaskill P, Balleine RL, Bilous M, Pegram MD.

Breast Cancer Res Treat. 2011 Oct;129(3):659-74. doi: 10.1007/s10549-011-1632-x. Epub 2011 Jun 23.

PMID:
21698410
18.

Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice.

Farshid G, Armes JE, Bell R, Cummings M, Fox S, Francis G, Haswell M, Morey A, McCue G, Raymond W, Robbins P, Bilous M.

Diagn Mol Pathol. 2010 Dec;19(4):187-93. doi: 10.1097/PDM.0b013e3181e1cc9d.

PMID:
21052003
19.

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.

Da Silva L, Simpson PT, Smart CE, Cocciardi S, Waddell N, Lane A, Morrison BJ, Vargas AC, Healey S, Beesley J, Pakkiri P, Parry S, Kurniawan N, Reid L, Keith P, Faria P, Pereira E, Skalova A, Bilous M, Balleine RL, Do H, Dobrovic A, Fox S, Franco M, Reynolds B, Khanna KK, Cummings M, Chenevix-Trench G, Lakhani SR.

Breast Cancer Res. 2010;12(4):R46. doi: 10.1186/bcr2603. Epub 2010 Jul 6.

20.

Prevalence and nature of anaemia in a prospective, population-based sample of people with diabetes: Teesside anaemia in diabetes (TAD) study.

Jones SC, Smith D, Nag S, Bilous MT, Winship S, Wood A, Bilous RW.

Diabet Med. 2010 Jun;27(6):655-9. doi: 10.1111/j.1464-5491.2010.02987.x.

PMID:
20546283

Supplemental Content

Loading ...
Support Center